Imaging of non alcoholic fatty liver disease: A road less travelled
| Autor: | Manas P Baruah, Divya Singh, Chandan J Das |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
In vivo magnetic resonance spectroscopy
medicine.medical_specialty Cirrhosis Endocrinology Diabetes and Metabolism Review Article Gastroenterology lcsh:Diseases of the endocrine glands. Clinical endocrinology Endocrinology Internal medicine medicine lcsh:RC799-869 lcsh:RC648-665 medicine.diagnostic_test business.industry hepatic steatosis Fatty liver MR spectroscopy Type 2 Diabetes Mellitus Magnetic resonance imaging computed tomography medicine.disease Obesity digestive system diseases Hepatocellular carcinoma sonoelastography lcsh:Diseases of the digestive system. Gastroenterology Elastography Radiology business Chemical shift imaging non alcoholic fatty liver disease |
| Zdroj: | Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 6, Pp 990-995 (2013) Indian Journal of Endocrinology and Metabolism |
| ISSN: | 2230-9500 2230-8210 |
| Popis: | Non alcoholic fatty liver disease (NAFLD) is a spectrum that includes simple steatosis, nonalcoholic steatohepatitis and cirrhosis. It is increasingly emerging as a cause of elevated liver enzymes, cryptogenic cirrhosis and hepatocellular carcinoma. The morbidity and mortality related to NAFLD is expected to rise with the upsurge of obesity and type 2 diabetes mellitus. The need of the hour is to devise techniques to estimate and then accurately follow-up hepatic fat content in patients with NAFLD. There are lots of imaging modalities in the radiological armamentarium, namely, ultrasonography with the extra edge of elastography, computed tomography, and magnetic resonance imaging with chemical shift imaging and spectroscopy to provide an estimation of hepatic fat content. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|